Variant report

Variant	esv3382561
Chromosome Location	chr7:100466516-100468564
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ELF1	chr7:100466286-100466579	K562	blood:	n/a	chr7:100466455-100466468
2	HEY1	chr7:100467715-100467987	K562	blood:	n/a	n/a
3	MAX	chr7:100464316-100466551	K562	blood:	n/a	chr7:100465338-100465348 chr7:100464740-100464747 chr7:100464920-100464931 chr7:100464921-100464930 chr7:100464916-100464935 chr7:100464730-100464746 chr7:100464666-100464676 chr7:100464919-100464932 chr7:100464739-100464748 chr7:100464921-100464930
4	PAX5	chr7:100466574-100466966	GM12878	blood:	n/a	n/a
5	POLR2A	chr7:100468216-100468534	Hela-S3	cervix:	n/a	n/a
6	POLR2A	chr7:100468165-100468184	MCF-7	breast:	n/a	n/a
7	POLR2A	chr7:100466468-100466636	K562	blood:	n/a	n/a
8	POLR2A	chr7:100468155-100468158	MCF-7	breast:	n/a	n/a
9	POLR2A	chr7:100467859-100468865	SK-N-MC	brain:	n/a	n/a
10	POLR2A	chr7:100468248-100468276	K562	blood:	n/a	n/a
11	POLR2A	chr7:100466115-100466558	U87	brain:	n/a	n/a
12	POLR2A	chr7:100467635-100467976	H1-hESC	embryonic stem cell:	n/a	n/a
13	POLR2A	chr7:100467918-100468210	K562	blood:	n/a	n/a
14	POLR2A	chr7:100466713-100467035	K562	blood:	n/a	n/a
15	POLR2A	chr7:100466805-100467038	H1-hESC	embryonic stem cell:	n/a	n/a
16	POLR2A	chr7:100468088-100468426	GM12892	blood:	n/a	n/a
17	POLR2A	chr7:100468012-100468540	H1-hESC	embryonic stem cell:	n/a	n/a
18	POLR2A	chr7:100468102-100468375	GM12878	blood:	n/a	n/a
19	POLR2A	chr7:100468073-100468386	ECC-1	luminal epithelium:	n/a	n/a
20	POLR2A	chr7:100468525-100468654	GM12878	blood:	n/a	n/a
21	POLR2A	chr7:100468043-100469471	K562	blood:	n/a	n/a
22	POLR2A	chr7:100468375-100468472	Hela-S3	cervix:	n/a	n/a
23	POLR2A	chr7:100464039-100466627	K562	blood:	n/a	n/a
24	POLR2A	chr7:100463186-100466523	SK-N-MC	brain:	n/a	n/a
25	POLR2A	chr7:100468537-100468541	Hela-S3	cervix:	n/a	n/a
26	POLR2A	chr7:100464071-100466595	H1-hESC	embryonic stem cell:	n/a	n/a
27	POLR2A	chr7:100468550-100469322	K562	blood:	n/a	n/a
28	POLR2A	chr7:100467997-100468501	HL-60	blood:	n/a	n/a
29	POLR2A	chr7:100468127-100468162	HepG2	liver:	n/a	n/a
30	POLR2A	chr7:100467670-100468710	K562	blood:	n/a	n/a
31	POLR2A	chr7:100467985-100468485	H1-hESC	embryonic stem cell:	n/a	n/a
32	POLR2A	chr7:100467636-100468493	K562	blood:	n/a	n/a
33	POLR2A	chr7:100467723-100468378	Hela-S3	cervix:	n/a	n/a
34	POLR2A	chr7:100466881-100466954	HUVEC	blood vessel:	n/a	n/a
35	POLR2A	chr7:100468166-100468341	HepG2	liver:	n/a	n/a
36	POLR2A	chr7:100467547-100468878	H1-hESC	embryonic stem cell:	n/a	n/a
37	POLR2A	chr7:100468351-100468366	HepG2	liver:	n/a	n/a
38	POLR2A	chr7:100463396-100466627	U87	brain:	n/a	n/a
39	POLR2A	chr7:100468277-100468288	K562	blood:	n/a	n/a
40	POLR2A	chr7:100468282-100468643	K562	blood:	n/a	n/a
41	POLR2A	chr7:100467946-100468419	GM12878	blood:	n/a	n/a
42	POLR2A	chr7:100468236-100468247	K562	blood:	n/a	n/a
43	POLR2A	chr7:100467710-100469443	K562	blood:	n/a	n/a
44	POLR2A	chr7:100463164-100466642	HL-60	blood:	n/a	n/a
45	SPI1	chr7:100466287-100466616	HL-60	blood:	n/a	n/a
46	SPI1	chr7:100466311-100466551	K562	blood:	n/a	n/a
47	SPI1	chr7:100466364-100466584	K562	blood:	n/a	n/a
48	SPI1	chr7:100466183-100466631	HL-60	blood:	n/a	n/a
49	SPI1	chr7:100466345-100466613	GM12878	blood:	n/a	n/a
50	YY1	chr7:100466474-100466604	K562	blood:	n/a	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr7:100448636..100452358-chr7:100462094..100466806,6	K562	blood:
2	chr7:100448977..100453392-chr7:100463620..100466806,5	K562	blood:

Variant related genes	Relation type
TRIP6	TF binding region
SRRT	TF binding region
ENSG00000236305	chromatin interactions
ENSG00000146828	chromatin interactions

Extended variants
information (count: 107 )
Associated
traits (count: 93 )

Variant overlapped rSNPs/rCNVs (count:107 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs201835823	chr7:100466528-100466529	Weak transcription Genic enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs562434403	chr7:100466529-100466530	Weak transcription Genic enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs201624785	chr7:100466538-100466539	Weak transcription Genic enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs558245114	chr7:100466548-100466549	Weak transcription Genic enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs577484866	chr7:100466556-100466557	Weak transcription Genic enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs541708902	chr7:100466594-100466595	Weak transcription Genic enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs376626926	chr7:100466608-100466609	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs546424451	chr7:100466648-100466649	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs553612180	chr7:100466666-100466667	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs184574885	chr7:100466753-100466754	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs542440455	chr7:100466757-100466758	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs563847240	chr7:100466843-100466844	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs377055463	chr7:100466869-100466870	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs530896748	chr7:100466944-100466945	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs567852910	chr7:100466973-100466974	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs546210260	chr7:100466980-100466981	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs188891142	chr7:100466982-100466983	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs532290255	chr7:100466983-100466984	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs547249488	chr7:100467025-100467026	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs565543399	chr7:100467026-100467027	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs181592587	chr7:100467053-100467054	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs548065690	chr7:100467062-100467063	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs534956985	chr7:100467084-100467085	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs112488282	chr7:100467123-100467124	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs186564890	chr7:100467145-100467146	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs558536575	chr7:100467175-100467176	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs570420424	chr7:100467202-100467203	Weak transcription Strong transcription Genic enhancers Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs535336027	chr7:100467218-100467219	Weak transcription Strong transcription Genic enhancers Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs141272392	chr7:100467222-100467223	Weak transcription Strong transcription Genic enhancers Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs553597845	chr7:100467291-100467292	Weak transcription Strong transcription Genic enhancers Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs562931696	chr7:100467328-100467329	Weak transcription Strong transcription Genic enhancers Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs369936612	chr7:100467350-100467351	Weak transcription Strong transcription Genic enhancers Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs557253769	chr7:100467475-100467476	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs575715521	chr7:100467480-100467481	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs192236476	chr7:100467485-100467486	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs564515917	chr7:100467505-100467506	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs73396638	chr7:100467523-100467524	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs540222847	chr7:100467549-100467550	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs559255434	chr7:100467575-100467576	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs34982581	chr7:100467603-100467604	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs2571597	chr7:100467653-100467654	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs548385942	chr7:100467656-100467657	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs554852044	chr7:100467672-100467673	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs12705090	chr7:100467700-100467701	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
45	rs74799213	chr7:100467739-100467740	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs551936369	chr7:100467784-100467785	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
47	rs570557103	chr7:100467785-100467786	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
48	rs534646693	chr7:100467787-100467788	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs552991273	chr7:100467792-100467793	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs112832399	chr7:100467815-100467816	Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:93)

Disease	PMID	Source
Basal cell lymphoma	17170743	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Non-small cell lung cancer	21829676	CNVD
Gastric cancer	24379144	CNVD
Glioblastoma multiforme	17002787	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lissencephaly	21572526	CNVD
Breast cancer	17603634	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	16397240	CNVD
Acute myeloid leukemia	16864856	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Multiple myeloma	17550852	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neurodevelopmental disorder	22521361	CNVD
abortions and stillbirths	19751515	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Metanephric adenoma	20802469	CNVD
Prostate cancer	16461572	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Burkitt''s lymphoma	19759907	CNVD
Malignant melanoma	17260012	CNVD
Myelodysplastic syndrome	21251322	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Chronic myeloid leukemia	21384125	CNVD
Bladder cancer	21909424	CNVD
Biliary cancer	19435499	CNVD
Myelofibrosis	22110671	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	16608533	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Liver carcinoma	19366792	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Adenocarcinoma	19607727	CNVD
Multiple myeloma	16461302	CNVD
Breast cancer	21858162	CNVD
Emphysema	19352772	CNVD
Effusion lymphoma	18079361	CNVD
Medulloblastoma	17653508	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Autism	19401682	CNVD
Neuroticism	17667963	CNVD
Breast cancer	21509527	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Prostate cancer	18632612	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	21364760	CNVD
Breast cancer	20409316	CNVD
aortic dissecting aneurysms	22263138	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:295 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:100461800-100471400	Weak transcription	HepG2	liver
2	chr7:100463600-100466600	Flanking Active TSS	Stomach Smooth Muscle	stomach
3	chr7:100464000-100466600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
4	chr7:100464000-100466600	Flanking Active TSS	Adipose Nuclei	Adipose
5	chr7:100464400-100466600	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
6	chr7:100464600-100466600	Active TSS	Esophagus	oesophagus
7	chr7:100464600-100466800	Active TSS	iPS-15b Cell Line	embryonic stem cell
8	chr7:100464800-100467000	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
9	chr7:100464800-100467000	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
10	chr7:100464800-100467000	Active TSS	HSMM	muscle
11	chr7:100464800-100467200	Active TSS	NHDF-Ad	bronchial
12	chr7:100465400-100466600	Enhancers	Primary B cells from cord blood	blood
13	chr7:100465400-100467800	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
14	chr7:100465600-100466600	Flanking Active TSS	HUVEC	blood vessel
15	chr7:100465600-100466800	Flanking Active TSS	K562	blood
16	chr7:100465600-100467000	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
17	chr7:100465600-100467000	Enhancers	Primary neutrophils fromperipheralblood	blood
18	chr7:100465600-100467000	Transcr. at gene 5' and 3'	Foreskin Fibroblast Primary Cells skin02	Skin
19	chr7:100465600-100467000	Transcr. at gene 5' and 3'	Dnd41	blood
20	chr7:100465600-100471800	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
21	chr7:100465600-100471800	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
22	chr7:100465600-100471800	Weak transcription	Primary T killer memory cells from peripheral blood	blood
23	chr7:100465600-100472000	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
24	chr7:100465800-100466600	Flanking Active TSS	Liver	Liver
25	chr7:100465800-100466600	Transcr. at gene 5' and 3'	Fetal Stomach	stomach
26	chr7:100465800-100466600	Flanking Active TSS	Rectal Smooth Muscle	rectum
27	chr7:100465800-100466800	Transcr. at gene 5' and 3'	IMR90 fetal lung fibroblasts Cell Line	lung
28	chr7:100465800-100466800	Enhancers	Stomach Mucosa	stomach
29	chr7:100465800-100466800	Flanking Active TSS	NH-A	brain
30	chr7:100465800-100467000	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
31	chr7:100465800-100467000	Flanking Active TSS	Hela-S3	cervix
32	chr7:100465800-100467400	Transcr. at gene 5' and 3'	NHLF	lung
33	chr7:100465800-100467800	Weak transcription	Primary T helper naive cells from peripheral blood	blood
34	chr7:100465800-100469400	Transcr. at gene 5' and 3'	Foreskin Fibroblast Primary Cells skin01	Skin
35	chr7:100465800-100472000	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
36	chr7:100466000-100466600	Flanking Active TSS	Colon Smooth Muscle	Colon
37	chr7:100466000-100466600	Flanking Active TSS	Duodenum Smooth Muscle	Duodenum
38	chr7:100466000-100466600	Flanking Active TSS	Fetal Intestine Large	intestine
39	chr7:100466000-100466600	Transcr. at gene 5' and 3'	Fetal Intestine Small	intestine
40	chr7:100466000-100466600	Transcr. at gene 5' and 3'	Fetal Muscle Trunk	muscle
41	chr7:100466000-100466600	Transcr. at gene 5' and 3'	Fetal Muscle Leg	muscle
42	chr7:100466000-100467000	Transcr. at gene 5' and 3'	NHEK	skin
43	chr7:100466000-100467200	Transcr. at gene 5' and 3'	Foreskin Melanocyte Primary Cells skin03	Skin
44	chr7:100466000-100467400	Transcr. at gene 5' and 3'	Foreskin Keratinocyte Primary Cells skin03	Skin
45	chr7:100466000-100467800	Weak transcription	Gastric	stomach
46	chr7:100466000-100468000	Weak transcription	Primary T cells from cord blood	blood
47	chr7:100466000-100468000	Weak transcription	Sigmoid Colon	Sigmoid Colon
48	chr7:100466000-100471600	Weak transcription	Primary T helper cells PMA-I stimulated	--
49	chr7:100466000-100471800	Weak transcription	Fetal Brain Male	brain
50	chr7:100466200-100466600	Transcr. at gene 5' and 3'	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links